Evidence map›Paper›PMID 36249427›Full record

ArticleJournal of immunology research2022

Expression Analysis of Ligand-Receptor Pairs Identifies Cell-to-Cell Crosstalk between Macrophages and Tumor Cells in Lung Adenocarcinoma.

Xiaodong Yang, Zhao An, Zhengyang Hu, Junjie Xi, Chenyang Dai, Yuming Zhu

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiaodong YangDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.ORCID https://orcid.org/0000-0002-9221-5812
Zhao AnDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.ORCID https://orcid.org/0000-0001-6203-1062
Zhengyang HuDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0003-4541-1826
Junjie XiDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0002-1766-7149
Chenyang DaiDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.ORCID https://orcid.org/0000-0001-9609-0343
Yuming ZhuDepartment of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.ORCID https://orcid.org/0000-0002-4833-4240
Tongji University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lung adenocarcinoma is one of the most commonly diagnosed malignancies worldwide. Macrophage plays crucial roles in the tumor microenvironment, but its autocrine network and communications with tumor cell are still unclear. Methods: We acquired single-cell RNA sequencing (scRNA-seq) ( Results: A total of 159,219 single cells (18,248 tumor cells and 29,520 macrophages) were selected in this study. We identified significantly correlated autocrine ligand-receptor gene pairs in tumor cells and macrophages, respectively. Furthermore, we explored the cell-to-cell communications between macrophages and tumor cells and detected significantly correlated ligand-receptor signaling pairs. We determined that some of the hub gene pairs were associated with patient prognosis and constructed a machine-learning model based on the intercellular interaction network. Conclusion: We revealed significant cell-to-cell communications (both autocrine and paracrine network) within macrophages and tumor cells in lung adenocarcinoma. Hub genes with prognostic significance in the network were also identified.

Indexed as

Adenocarcinoma of LungLung NeoplasmsBiomarkers, TumorGene Expression ProfilingHumansLigandsMacrophagesPrognosisTumor MicroenvironmentBiomarkers, TumorLigands

Identifiers

PMID36249427
PMCPMC9553453
OpenAlexW4296917223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.